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Naturally acquired antibody 
response to Plasmodium falciparum 
describes heterogeneity in 
transmission on islands in Lake 
Victoria
Zulkarnain Md Idris1,2, Chim W. Chan2, James Kongere3, Tom Hall4, John Logedi5, Jesse Gitaka6, 
Chris Drakeley4 & Akira Kaneko2,7,8
As markers of exposure anti-malaria antibody responses can help characterise heterogeneity in malaria 
transmission. In the present study antibody responses to Plasmodium falciparum AMA-1, MSP-119 and 
CSP were measured with the aim to describe transmission patterns in meso-endemic settings in Lake 
Victoria. Two cross-sectional surveys were conducted in Lake Victoria in January and August 2012. The 
study area comprised of three settings: mainland (Ungoye), large island (Mfangano) and small islands 
(Takawiri, Kibuogi, Ngodhe). Individuals provided a finger-blood sample to assess malaria infection 
by microscopy and PCR. Antibody response to P. falciparum was determined in 4,112 individuals by 
ELISA using eluted dried blood from filter paper. The overall seroprevalence was 64.0% for AMA-1, 
39.5% for MSP-119, and 12.9% for CSP. Between settings, seroprevalences for merozoite antigens were 
similar between Ungoye and Mfangano, but higher when compared to the small islands. For AMA-1, 
the seroconversion rates (SCRs) ranged from 0.121 (Ngodhe) to 0.202 (Ungoye), and were strongly 
correlated to parasite prevalence. We observed heterogeneity in serological indices across study sites in 
Lake Victoria. These data suggest that AMA-1 and MSP-119 sero-epidemiological analysis may provide 
further evidence in assessing variation in malaria exposure and evaluating malaria control efforts in high 
endemic area.
In sub-Saharan Africa, malaria remains one of the leading causes of morbidity and mortality, with 191 million 
cases and over 390 thousand deaths reported in 20161. Nevertheless, with scaling up of malaria prevention, diag-
nosis and treatment, the prevalence of Plasmodium falciparum infection in many parts of sub-Saharan Africa 
declined by 50%, and the incidence of clinical disease fell by 40% between 2000 and 20152.
In Kenya, 65% (26 million) of the population live in areas where P. falciparum parasite rate for the pop-
ulation aged 2–10 years (PfPR2–10) is below 1%3. Despite significant increases in coverage of long-lasting 
insecticide-treated nets (LLINs) through free-mass distribution campaigns4 and the change in first-line treatment 
to artemisinin-based combination therapy (ACT)5, 10.6% (4.3 million) of the population still live in areas with 
PfPR2–10 ≥ 40%, mainly counties adjacent to Lake Victoria in western Kenya6. In addition, increased paediatric 
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malaria hospital admissions in 20097 and high prevalence of malaria infection among school children in 20148 
highlight the challenge of effective malaria control in this highly endemic region of Kenya.
Understanding the intensity of malaria transmission in a community is fundamental to the design and eval-
uation of malaria control and elimination programmes. The most widely used metric of malaria transmission 
Figure 1. Map of the study area in Lake Victoria in western Kenya (inset) showing the proportion of 
Plasmodium spp. infection and P. falciparum seroprevalence. The population of three main areas were subjected 
in this study: mainland coastal village (Ungoye; area shown in red dashed line), large island (Mfangano) 
and three small islands (Takawiri, Kibuogi and Ngodhe). The black, red and green pies are proportions of P. 
falciparum, P. malariae and P. ovale, respectively. A number in each pie graph is the proportion of P. falciparum 
infection or seropositive. Yellow and blue circles pointed the surveyed catchment areas in January 2012 and 
August 2012, respectively. The most populated small towns are shown in red circle. LM is light microscopy and 
PCR is nested PCR. The map was created with ArcGIS software, version 10.4, http://www.esri.com.
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intensity is parasite prevalence, measured through cross-sectional surveys. In recent years, antibody responses 
to one or more malaria parasite-specific antigens have been explored as alternative means to estimate malaria 
transmission intensity9, 10. As a proxy measure of malaria transmission, serological responses to P. falciparum 
antigens have shown a robust and consistent correlation with estimates of entomological inoculation rate (EIR)10, 
and thus have increasingly been incorporated in cross-sectional and longitudinal studies to monitor changes in 
transmission11–15 and identify hotspots in transmission16, 17.
Whilst several sero-epidemiological studies have been conducted in the low-transmission western highlands 
of Kenya18–20, no such study has been carried out in the adjacent Lake Victoria basin where prevalence is mod-
erate to high with significant local heterogeneity21. In the present study, antibody responses to P. falciparum 
blood-stages antigens apical membrane antigen 1 (AMA-1), merozoite surface antigen-119 (MSP-119) and cir-
cumsporozoite antigen (CSP) were measured to assess malaria exposure and transmission on islands in Lake 
Victoria. Results from this study provide baseline data to evaluate the planned malaria elimination programme 
in the study area.
Results
Characteristics and parasite rates of the study participants. A total of 5044 participants were 
enrolled from five different settings (336–1947 individuals per site) in January and August 2012. Population 
coverage varied among settings: 10.5% in Mfangano, 35.7% in Ungoye and 48–90.6% in the small islands. Gender 
and age distributions were similar across the five settings. The majority of participants were children and adoles-
cents ≤15 years old (73.0%, 95% CI: 71.7–74.2) and came from the islands (75.4%, 95% CI: 74.2–76.6). At enrol-
ment, 5.9% (95% CI: 5.2–6.5) of the population were febrile (axillary temperature >37.5 °C), and 20.8% (95% CI: 
19.7–22.0) were anaemic (haemoglobin [Hb] level < 11 g/dL). Of all children 12 years and below (n = 3045), 1261 
(41.4%; 95% CI: 39.7–43.2) were found to have an enlarged spleen. The prevalence of febrile illness, anaemia, and 
enlarged spleen varied significantly by study sites (P < 0.001). Further details on the study population are shown 
in Table 1.
The prevalence of P. falciparum infection by microscopy and PCR in the study sites is shown in Fig. 1. P. fal-
ciparum parasite prevalence ranged between 4.1 and 32.1% by microscopy, and between 11.2 and 56.2% by PCR. 
Parasite prevalence was significantly higher in Ungoye than other sites, regardless of detection method (P < 0.001 
for all comparisons). Parasite prevalence by PCR generally peaked in the 11–15 years group and declined there-
after in all study sites (Fig. 2A). There were no statistically significant differences in mean parasite density among 
study sites after adjusting for age (P = 0.091). Geographic heterogeneities in malaria prevalence, sub-microscopic 
infections, and distribution of Plasmodium spp. in the study area have been reported previously21.
Naturally acquired antibody responses against malaria antigens. AMA-1 antibodies. Antibody 
responses to AMA-1, whether evaluated as OD level, antibody titre or SCR, generally increased with increasing 
malaria prevalence (Table 2). The overall seroprevalence was 64% (95% CI: 62.5–65.5). Seroprevalence was sig-
nificantly higher (P < 0.001 for all comparisons) in Ungoye (68.6%; 95% CI: 65.3–71.6) and Mfangano (66.3%; 
95% CI: 63.9–68.7) than Takawiri (60.5%; 95% CI: 56.0–64.0), Kibuogi (58.5%; 95% CI: 52.9–63.9) and Ngodhe 
(58.4%; 95% CI: 54.3–62.5) (Fig. 1). Seroprevalence of males and females in all study areas were comparable. 
Antibody responses increased with age (P < 0.001) and antibody prevalence rapidly rose in children aged 6–10 
years in all study areas (Fig. 2B). More than 75% of participants became seropositive by 20 years of age (Fig. 2A), 
Characteristic
Study site
Overall Ungoye Mfangano Takawiri Kibuogi Ngodhe
Total number of study 
participants 5044 1239 1947 888 336 634
Female gender, n (%) 2623 (52.2) 628 (50.7) 998 (51.3) 468 (52.9) 194 (57.7) 344 (54.3)
Age, median (IQR), years 10 (6–18) 10 (5–13) 11 (6–18) 10 (5–20) 10 (5–20) 12 (7–23)
0–5 1211 (24.0) 345 (27.9) 396 (23.4) 233 (26.3) 102 (30.4) 135 (21.3)
6–10 1319 (26.2) 362 (29.2) 526 (27.0) 228 (25.8) 72 (21.4) 131 (20.7)
11–15 1146 (22.8) 298 (24.1) 502 (25.8) 171 (19.3) 41 (12.2) 134 (21.2)
16–30 756 (15.0) 123 (9.9) 266 (13.7) 160 (18.1) 84 (25.0) 123 (19.4)
>30 606 (12.0) 110 (8.9) 256 (13.2) 93 (10.5) 37 (11.0) 110 (17.4)
Axillary temperature, 
Mean ± SD, °C 36.9 ± 0.6 36.9 ± 0.7 36.9 ± 0.6 36.8 ± 0.5 36.7 ± 0.5 36.8 ± 0.6
Temperature > 37.5 °C at 
time of survey, n (%) 295 (5.9) 118 (9.5) 105 (5.4) 32 (3.6) 9 (2.7) 31 (4.9)
Haemoglobin (Hb) level, 
Mean ± SD, g/dL 12.5 ± 2.1 12.5 ± 1.8 12.6 ± 2.0 12.1 ± 2.3 12.7 ± 2.1 12.2 ± 2.2
Proportion anaemic (<11 g/
dL), n (%) 1049 (20.8) 214 (17.3) 368 (18.9) 245 (27.7) 66 (19.7) 156 (24.6)
Enlarged spleen, n (%) 1261 (41.4) 584/948 (61.6) 438/1160 (37.8) 129/548 (23.5) 73/180 (40.6) 37/209 (17.7)
Table 1. Demographic characteristics of all surveyed population. *No gender and age recorded, n = 6; Body 
temperature, N = 5038; Hb level, N = 5035; Spleen test, N = 3045; IQR, interquartile range, SD; standard 
deviation.
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indicating rapid acquisition of antibodies with repeated infection. Estimated EIRs based on SCRs10 were 12, 7, 
4, 4, and 3 infectious bites per person per year (ib/p/yr) for Ungoye, Mfangano, Takawiri, Kibuogi, and Ngodhe, 
respectively (Table 2). The age-seroprevalence curves did not indicate more than one force of infection over time; 
this was checked by allowing the SCR to differ at a single time point (Fig. 3A). Across the study sites, SCRs cor-
related significantly with P. falciparum parasite rates by microscopy (Correlation of determination, R2: 0.9402, 
P = 0.009) and PCR (R2: 0.9601, P < 0.001) (Fig. 4).
MSP-119 antibodies. Median MSP-119 antibody OD levels and titres, as well as seroprevalence were lower than 
their corresponding AMA-1 measures across the five study sites (Fig. 1, Table 2). The overall seroprevalence 
was 39.5% (95% CI: 37.9–41.0). Seropositivity to MSP-119 was similar (P = 0.382) between Ungoye (43.4%) 
and Mfangano (45.4%), and significantly lower on the three small islands (P < 0.001 for all comparisons). 
Seroprevalence between genders showed a higher prevalence in females in Ungoye (P = 0.023) and Mfangano 
(P = 0.024), but the differences were comparable in the small islands. Antibody level and seroprevalence increased 
significantly with age (P < 0.001) in all study areas (Fig. 2B). The acquisition of antibodies to MSP-119 was mod-
erate, with only 40% of participants becoming seropositive by 20 years of age (Fig. 3B). MSP-119 SCRs were 
approximately 0.08 for Ungoye and Mfangano and 0.05 for the small islands, which corresponded to calculated 
aEIRs of 7 ib/p/yr in Ungoye and Mfangano, but only fewer than 3 ib/p/yr on the small islands (Fig. 3B, Table 2). 
Nevertheless, SCRs were not statistically significant across the study sites as evidenced by the overlapping confi-
dence intervals. Similar to AMA-1, MSP-119 SCRs showed significant correlation with P. falciparum parasite rates 
(microscopy, R2: 0.8875, P = 0.017; PCR, R2: 0.9446, P = 0.007) (Fig. 4).
CSP antibodies. The overall seroprevalence for CSP was 12.9% (95% CI: 11.9–13.9). The different serological 
outcomes for CSP all produced similar trends; similar between the study areas, albeit the differences in antibody 
responses were statistically lower than AMA-1 and MSP-119 (P < 0.001 for all comparisons) (Fig. 1, Table 2). 
Seroprevalence of males and females in all study areas were comparable. Antibody level and seroprevalence 
increased with age group in all study sites (P < 0.001) (Fig. 2B), and the acquisition of antibodies to CSP was 
slow, with <20% of participants becoming seropositive by 20 years of age (Fig. 3C). SCRs were not significantly 
different among study sites and were not significantly correlated with P. falciparum parasite rate (microscopy, 
P = 0.869; PCR, P = 0.986) (Fig. 4A).
Antibody responses among P. falciparum-infected populations. Figure 5 shows age-adjusted antibody responses 
to parasite antigens among PCR-confirmed P. falciparum infected individuals. Antibody responses did not dif-
fer significantly between the febrile and the non-febrile groups in all study sites, but the proportions of AMA-1 
seropositive individuals were significantly higher (P < 0.05) in the non-febrile groups in Ungoye and Mfangano 
(Fig. 5A). When stratified by anaemia (Hb level < 11 g/dL), total anti-AMA-1 IgG levels were significantly higher 
Figure 2. Age-specific prevalence of P. falciparum parasites and antimalarial antibody responses by setting. 
(A) The prevalence of P. falciparum (as determined by microscopy and PCR), and (B) optical density (OD) and 
respective seroprevalence to AMA-1, MSP-119 and CSP (as determined by ELISA) in each setting by age group. 
Data are shown for both surveys combined. The total numbers of sample tested were; microscopy, n = 5012; 
PCR, n = 4946; ELISA, n = 4112. Error bar represents 95% confidence interval (CI) or interquartile range (IQR, 
25th – 75th percentile).
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(P < 0.01) among the non-anaemic group than the anaemic group in all island settings (Fig. 5B). Among chil-
dren ≤12 years old, those with enlarged spleen had significantly higher (P < 0.01) levels of IgG against CSP in 
all settings. Levels of IgG against AMA-1 and MSP119 were significantly higher (P < 0.01) among children with 
enlarged spleen than those with non-palpable spleen in Ungoye and Mfangano, although the differences were not 
consistently observed on the small islands (Fig. 5C).
Antibody responses to parasite antigens were analysed in relation to parasite density. Antibody levels 
were not significantly different between those with microscopic infections and those with sub-microscopic 
(microscopy-negative but PCR-positive) infections (Supplementary Fig. S1). Among those with microscopically 
confirmed infections, no significant differences in antibody responses were observed between those with low 
(<5000 parasite/µl) and high (≥5000 parasite/µl) asexual parasite densities (Supplementary Fig. S1).
Factors associated with seropositivity. In the adjusted model, age was significantly (P < 0.005) associated with 
seropositivity to AMA-1, MSP-119 and CSP in all five study sites. Anaemia was significantly associated with seron-
egativity to AMA-1 on Mfangano (P = 0.018), Kibuogi (P = 0.008), and Ngodhe (P = 0.037) (Table 3). When 
restricted to children 12 years and below, enlarged spleen was significantly associated with seropositivitiy to 
all three parasite antigens in Ungoye (P < 0.01), Mfangano (P < 0.001), and Takawiri (P < 0.005). Enlarged 
spleen was also significantly associated with seropositivity to AMA-1 (P = 0.005) on Kibuogi, and seropositiv-
ity to MSP-119 (P < 0.001) and CSP (P = 0.002) on Ngodhe. Age was significantly (P < 0.001) associated with 
AMA-1 seropositivity in all five study sites, MSP-119 seropositivity in Ungoye (P < 0.001), and CSP seropositivity 
on Ngodhe (P = 0.024). Significant association between anaemia and MSP-119 seropositivity was observed in 
Ungoye (P = 0.012) and Mfangano (P = 0.03) only (Table 4).
Category Characteristic
Study site
Ungoye Mfangano Takawiri Kibuogi Ngodhe
Sample size
Number of sample for microscopy 1238 1938 883 336 633
Number of sample for PCR 1237 1938 883 336 632
Number of sample for ELISA 868 1574 770 325 575
Blood smear 
microscopy
Positive for Plasmodium spp., 
n (%) 403 (32.6) 393 (20.3) 38 (4.3) 21 (6.3) 39 (6.2)
Geometric mean parasite density, 
parasite/µl (95% CI)
1101 
(942–1286)
1045 
(877–1245)
1458  
(841–2526)
1665  
(641–4326)
1229 
(657–2298)
P. falciparum parasite rate in 
children 2–10 years1, n/N2 (%)
263/669 
(39.3)
211/846 
(24.9) 24/419 (5.7)
11/146  
(7.5)
25/234  
(10.7)
P. falciparum gametocytes rate, 
n/N3 (%) 41/397 (10.3) 34/358 (9.5) 2/36 (5.6) 5/21 (23.8)
3/39  
(7.7)
PCR
Positive for Plasmodium spp., 
n (%) 1048 (84.7) 1033 (53.3) 153 (17.3) 60 (17.9) 82 (13.0)
P. falciparum parasite rate in 
children 2–10 years, n/N2 (%)
433/669 
(64.7)
366/847 
(43.2) 62/420 (14.8) 26/146 (17.8) 35/234 (15.0)
ELISA
Median AMA-1 OD (IQR) 0.89 (0.48–1.08)
0.79 
(0.33–1.06)
0.35 
(0.09–0.82)
0.48  
(0.14–0.92)
0.40 
(0.13–0.83)
Median AMA-1 antibody titre 
(IQR)
1579 
(358–5564)
1001 
(189–4083)
194 
(40–1082)
295  
(44–1418)
225 
(47–1025)
AMA-1 SCR, (95% CI) 0.204  (0.181–0.228)
0.166  
(0.153–0.181)
0.139  
(0.123–0.156)
0.136  
(0.113–0.165)
0.122  
(0.106–0.141)
AMA-1 estimate EIR4 (95% CI) 12.1 (8.9–16.2) 7.1 (5.7–8.9) 4.4 (3.2–6.0) 4.2 (2.6–7.0) 3.2 (2.2–4.6)
Median MSP-119 OD (IQR)
0.30 
(0.13–0.81)
0.33 
(0.17–0.79)
0.19 
(0.11–0.43)
0.20  
(0.12–0.51)
0.18 
(0.11–0.43)
Median MSP-119 antibody titre 
(IQR) 96 (33–580) 118 (45–530) 43 (24–162) 52 (28–217) 41 (22–131)
MSP-119 SCR, (95% CI)
0.079  
(0.070–0.089)
0.075  
(0.069–0.082)
0.043 
(0.037–0.049)
0.048  
(0.039–0.060)
0.046  
(0.039–0.054)
MSP-119 estimate EIR4 (95% CI) 7.1 (5.5–9.2) 6.4 (5.4–7.7) 2.0 (1.4–2.6) 2.5 (1.6–4.0)
2.3  
(1.6–3.2)
Median CSP OD (IQR) 0.40 (0.22–0.68)
0.41 
(0.26–0.72)
0.24 
(0.12–0.41)
0.29  
(0.20–0.44)
0.24 
(0.14–0.40)
Median CSP antibody titre (IQR) 385 (207–834) 446  (246–946)
221 
(106–406)
245  
(153–433)
219 
(123–422)
CSP SCR, (95% CI) 0.008  (0.006–0.010)
0.011  
(0.010–0.013)
0.008 
(0.006–0.010)
0.010 (0.007–
0.014)
0.009  
(0.007–0.011)
Table 2. Estimates of current malaria infection and exposure. 1Total of two children has no data on microscopy. 
2Total numbers of children 2–10 years old tested. 3Total P. falciparum positive by slide microscopy. 4EIR was 
estimated from the SCR data using a previously described relationship10. OD, optical density; CI, confidence 
interval; IQR, interquartile range (25th–75th percentile); SCR, seroconversion rate.
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Discussion
This study describes data on parasite prevalence and antibodies responses to AMA-1, MSP-119 and CSP antigens 
of P. falciparum in 5,044 individuals living on a coastal area and four different islands in Lake Victoria, Kenya. 
The present study demonstrates a clear relation of serological outcomes for AMA-1 and MSP-119 with parasite 
prevalence and serology-derived EIR in heterogeneity of malaria transmission in the study area. AMA-1 exhibited 
the highest seroprevalence of the three antigens tested; AMA-1 seroprevalence was typically two- to four-fold 
greater than that for MSP-119 and CSP between each study area. The relationship between age and parasite prev-
alence was similar in all five areas, increasing with age until peaking by 11–15 years and then decreasing with 
Figure 3. Annual probability of seroconversion rate for specific malaria antigen by age in each setting. 
Maximum-likelihood fits from reversible catalytic equilibrium model from each setting are shown. λ, the area-
specific annual rate of seroconversion. (A) AMA-1, (B) MSP-119, (C) CSP. The model was constrained to fit a 
single value for the annual probability of a common seroreversion rate (ρ), which was estimated; AMA-1: 0.0377 
(95% CI 0.0312–0.0456); MSP-119: 0.0433 (95% CI 0.0330–0.0568); CSP: 0.0011 (95% CI 0.0000–0.61138). 
Points indicated observed seroprevalence and solid lines show model-predicted seroprevalence. Broken lines 
are 95% confidence intervals.
Figure 4. Association between the annual rate of seroconversion and P. falciparum parasite rate in the study 
area. Plot of estimate of seroconversion rates (λ) (calculated as for Table 2) against P. falciparum parasite rates 
by (A) microscopy, and (B) PCR. Un = Ungoye, Mf = Mfangano Island, Ta = Takawiri Island, Ki = Kibuogi 
Island, and Ng = Ngodhe Island.
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age. Seroprevalence and seroconversion data showed clear increases in seroreactivity with age and independently 
associated with enlarged spleen in children below 12 years old.
We examined the cross-sectional data to investigate the capability of antigens tested to pick up current differ-
ences in malaria prevalence. We observed heterogeneity in age-seropositivity between the study areas. Although 
seroprevalence showed less marked difference in P. falciparum exposure between the study areas, SCR showed 
a distinct variation in transmission intensity. SCRs for P. falciparum merozoite antigens (i.e. AMA-1, MSP-119) 
Figure 5. Age-adjusted antibody responses among P. falciparum infected individual (positive by PCR) for 
AMA-1, MSP-119 and CSP in each setting. (A) Presented with or without fever; stratified into non-febrile 
(axillary temperature ≤37.5 °C) and febrile (>37.5 °C) groups. (B) Presented with or without anaemia; stratified 
into anaemic (Hb level <11 g/dL) and non-anaemic (Hb level ≥11 g/dL) groups. (C) Presented with or without 
enlarged spleen among children ≤12 years old by Hackett’s method; stratified into enlarged spleen and normal 
groups. Data are presented in box plots (with the median shown as a line within the box and interquartile value 
(IQR, 25th–75th percentile) at the edge of box) and bar graphs (with Error bar represents 95% confidence 
interval (CI)). Any outlier values exceeding the interquartile range are shown as circles. Differences between 
the two groups of antibody levels were analysed by linear regression adjusting values for age (antibody level) 
and Chi-square test (proportion). *, ** and *** indicates significance at P < 0.05, P < 0.01 and P < 0.001, 
respectively.
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were similar between Ungoye and Mfangano, but significantly higher when compared to the three small islands 
(Table 2, Fig. 3). Furthermore, SCRs for both AMA-1 and MSP-119 consistently increased with increasing parasite 
prevalence in each area (Fig. 3). These results support the previous observations on the utility of AMA-1 and 
MSP-119 antibody prevalence and rate of antibody acquisition based on SCR as a reliable estimate of the level of 
transmission9, 10, 14, 22–27. MSP-119 has been proposed suitable for a wide range of transmission intensities9, 10, while 
AMA-1 suggested for low transmission setting9, 10, 28. The differences between the AMA-1 and MSP-119 estimates 
in malaria exposure or transmission may be linked to differences in seroconversion and reversion rates, and this 
could also explain the differences observed in our study. It is likely that seroconversion and reversion rates are 
different for different antigens, possibly reflecting their inherent immunogenicity, subclass dependent half-life, 
polymorphism etc. AMA-1 appears to be more immunogenic than MSP-1199, 10 and anti-AMA-1 titers tend to be 
higher than those for MSP-1199, suggesting that seroconversion may be faster and seroreversion may be slower for 
AMA-1 than for MSP-119.
Despite differences in immunogenicity, both P. falciparum AMA-1 and MSP-119 antibody prevalence have 
been previously demonstrated as useful surrogate markers for malaria transmission intensity in areas of low 
transmission22, 29–31. At low transmission intensities, SCR has high sensitivity since the longevity of the antibody 
response toward blood-stage antigens generates higher seroprevalence rates than equivalent parasite rates25. As a 
measure that integrates exposure over time and reflects cumuative exposure rather than single current infection 
(e.g. microscopy), SCR based on serology can provide a more robust picture of the malaria transmission dynam-
ics in an endemic area. In this setting, in the area with lack evidence of infections by microscopy, serological and 
molecular tools enabled a more complete understanding of the ongoing transmission and allowed for an exam-
ination of risk factors. Furthermore, as a metric of malaria transmission intensity, EIR is notoriously difficult to 
measure and the heterogeneous distribution of mosquito bites among individuals within a population makes 
it even more difficult to standardize32. Previously developed log-log calibration curves that relate SCRs to EIR 
values can provide a straightforward low-cost measure of malaria transmission9, 10. These serology-based EIR 
estimates, especially those based on MSP-119 SCR, have shown a robust correlation with measured EIR10, and thus 
allow for clear differentiation of low-, moderate-, and high-transmission areas.
Antibody responses to CSP did not follow the same pattern as those for merozoite antigens; neither sero-
prevalence nor SCR showed significant difference among settings. CSP has been previously reported to give 
reliable estimates of malaria endemicity in hyper-endemic areas and reflect the seasonal dynamics of trans-
mission33–36, making it a suitable marker for monitoring historical changes in transmission intensity14. AMA-1 
and MSP-119 are erythrocytic-stage antigens; they are produced continuously and in relative abundance 
because the erythrocytic-stage parasites go through several cycles of multiplication. In contrast, CSP is a 
pre-erythrocytic-stage antigen and is available to the immune system when a small number of sporozoites shed 
this antigen into circulation37. In consequence, the availability of CSP to immune system is of much shorter dura-
tion, which may explain its inability to detect subtle differences in exposure and transmission among settings in 
this study.
Factors associated to seroreactivity were identified by multivariable analyses in each study area. In all five 
areas, P. falciparum antibody prevalence increased with age. When analysed as a whole population, only antibody 
responses to AMA-1 were negatively associated with anaemia in Mfangano, Takawiri and Ngodhe. In contrast, 
when analysis was restricted in children ≤12 years, antibody responses to MSP-119 were significantly associated 
with anaemia in Ungoye and Mfangano, whilst all the antigens tested were independently associated with enlarged 
spleen in all areas. Associations between measured antibody responses to P. falciparum antigens and the risk of 
malaria have shown to be inconsistent in multiple studies38. Potential reasons for these inconsistencies include 
differences in the intensity and stability of transmission, allelic variation of specific antigens and IgG subclass 
switching39, which may explain some of the differences in findings in our study areas. Nevertheless, antibodies 
to AMA-1 have been associated with protection from clinical malaria in some studies38, 40, 41, but not others42, 43. 
Some studies have also documented independent association between antibodies to MSP-119 and protection from 
clinical malaria42, 44, whilst others have not45. Similar to the responses to blood-stage antigens, antibodies to CSP 
was associated with a higher odds of having an enlarged spleen, and age-adjusted antibody levels showed apparent 
high responses in children with enlarged spleen in each study area (Fig. 5C). This lack of protection to clinical 
malaria is consistent with prior studies44, 46 but in contrast with others47.
Setting Factor
AMA-1 MSP-119 CSP
aOR (95% CI) P value aOR (95% CI) P value aOR (95% CI) P value
Ungoye Age 1.02 (1.01–1.03) 0.002 1.06 (1.04–1.07) <0.001 1.05 (1.03–1.06) <0.001
Mfangano
Age 1.02 (1.01–1.03) <0.001 1.03 (1.02–1.04) <0.001 1.05 (1.04–1.05) <0.001
Anaemia 0.72 (0.56–0.95) 0.018 — — — —
Takawiri Age 1.09 (1.07–1.11) <0.001 1.02 (1.01–1.039 0.001 1.05 (1.04–1.06) <0.001
Kibuogi
Age 1.07 (1.04–1.09) <0.001 1.04 (1.02–1.06) <0.001 1.04 (1.02–1.06) <0.001
Anaemia 0.43 (0.23–0.80) 0.008 — — — —
Ngodhe
Age 1.06 (1.04–1.07) <0.001 1.05 81.03–1.06) <0.001 1.05 (1.03–1.06) <0.001
Anaemia 0.65 (0.43–0.97) 0.037 — — — —
Table 3. Factor associated with P. falciparum seroprevalence in four islands and a mainland village, Lake 
Victoria Kenya, 2012*. *aOR, adjusted odd ratio; CI, confidence interval. Estimates are adjusted (i.e. age, 
gender, fever and anaemia) for correlation between observations from the same setting.
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The influence of microscopically detectable parasite densities to prevalence and density of antibody responses 
in Kenyan children have been reported previously48, 49. This was only apparent in children <5 years of age and 
suggests that immune responses are less stable in this age group, fluctuating with concurrent infections48, 50. In 
older age groups, immune responses were not influenced by concurrent parasitaemia35. Contrary to previous 
findings, we did not find any evidence of increase antibody levels with parasite densities. Similarly, no evidence 
was found for a boosting of immune responses by sub-microscopic parasite carriage in our study areas, which 
is in agreement with a previous study in an intense malaria transmission setting in Uganda35, but not with other 
studies from low transmission settings51, 52. Nevertheless, sub-microscopic infections will provide an antigenic 
stimulus to maintain immune responses, but the role of sub-microscopic infections in maintaining immunity is 
yet to be quantified53.
This study has several limitations. First, the convenience sampling method used in this study has inherent 
selection bias. Most surveys were conducted in schools, meaning that children of school age (i.e. 6–15 years) were 
disproportionally represented (Table 1). Although this approach is valid in obtaining an estimate of antimalarial 
antibody prevalence25, over-representation of this age group among our samples likely overestimated the true 
malaria prevalence in the study area. Second, our surveys undersampled adult males that could have led to an 
underestimation of overall seroprevalence. Many adult males in the study area are engaged in fishing activities 
during daytime hours when our surveys were held. Malaria infections and immune status in this mobile and 
hard-to-reach group are not well characterised and warrant further investigation. Third, the survey design did 
not permit georeferencing of individual household locations and complete climate data from each study setting 
were unavailable. Therefore, no spatiotemporal analysis was possible to investigate patterns within individual 
sites or settings. A recent study screened over 800 Plasmodium antigens has identified serological markers of 
recent malaria infection54. Some of these markers may perform considerably better for the purpose of monitoring 
changes in transmission intensity.
Together these observations collectively suggest that serological analysis could be effective as an adjunct tool 
used in combination with parasite prevalence for surveillance, control and elimination of malaria in high endemic 
area. This study has demonstrated the potential of malaria antigens, namely AMA-1 and MSP-119, as important 
markers for assessing differences in malaria transmission in a moderate to high endemic area. The concurrent 
measurement of parasite prevalence and serology enabled us to compare malariometric indices across different 
endemicity settings and confirm the heterogeneity in malaria transmission between a relatively restricted geo-
graphical areas21. The use of serology in assessing naturally acquired immune responses to malaria can provide 
promising information for future research, particularly in evaluating control interventions for malaria elimina-
tion in high transmission settings where reductions are most difficult to achieve and sustain.
Methods
Study area. The present study was conducted on four islands in Lake Victoria (Mfangano, Takawiri, Kibuogi, 
Ngodhe) and one mainland lakeshore area (Ungoye) in Homa Bay County, western Kenya (Fig. 1). Homa Bay 
County has an area of 4,267 square kilometres (km2). The population in the study area consists mainly of peo-
ple of the Luo ethnic group with Dholuo is primarily spoken, as well as the national language of Kiswahili. 
Population estimates were 18,600 for Mfangano, 1000 for Takawiri, 700 each for Kibuogi and Ngodhe (Nagasaki 
University-Mbita Health and Demographic Surveillance System), and 3,471 for Ungoye (2009 Kenya Population 
and Housing Census). The area is predominantly rural with most residents depend on fishing and traditional 
small-scale farming as the main occupations21. Most houses are typically made of mud walls with thatched or 
corrugated iron roofs.
The climate in Lake Victoria is tropical, with temperatures ranging from a mean annual minimum of 17.7 °C to 
a mean annual maximum of 34.8 °C, and humidity is relatively high. This region generally experiences a bimodal 
Setting Factor
AMA-1 MSP-119 CSP
aOR (95% CI) P value aOR (95% CI) P value aOR (95% CI) P value
Ungoye
Age 1.21 (1.14–1.29) <0.001 1.21 (1.14–1.28) <0.001 — —
Enlarged spleen 4.17 (2.81–6.20) <0.001 2.30 (1.54–3.45) <0.001 4.52 81.54–13.22) 0.006
Anaemia — — 1.88 (1.15–3.00) 0.012 — —
Mfangano
Age 1.21 (1.15–1.27) <0.001 — — — —
Enlarged spleen 4.05 (2.95–5.53) <0.001 1.84 (1.38–2.45) <0.001 3.46 (1.93–5.79) <0.001
Anaemia — — 1.47 (1.04–2.08) 0.03 — —
Takawiri
Age 1.21 (1.13–1.29) <0.001 — — — —
Enlarged spleen 3.46 (2.07–5.78) <0.001 2.04 (1.26–3.32) 0.004 4.31 (1.78–10.48) 0.001
Kibuogi
Age 1.25 (1.11–1.42) <0.001 — — — —
Enlarged spleen 2.80 (1.37–5.72) 0.005 — — — —
Ngodhe
Age 1.34 (1.20–1.49) <0.001 — — 1.27 (1.03–1.57) 0.024
Enlarged spleen — — 5.11 (2.32–11.25) <0.001 6.46 (1.95–21.38) 0.002
Table 4. Factor associated with P. falciparum seroprevalence among children ≤12 years old in four islands and 
a mainland village, Lake Victoria Kenya, 2012*. *aOR, adjusted odd ratio; CI, confidence interval. Estimates 
are adjusted (i.e. age, gender, fever, anaemia and enlarged spleen) for correlation between observations from the 
same setting.
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pattern of rainfall, with the longer rainy season starting in March and ending in July and the shorter rainy season 
from November to December. In Lake Victoria basin, peak malaria transmission occurs 1–2 months after the 
rainy season and the mean monthly anopheline vector abundance has been reported to increase by 6- to 8-fold 
in the rainy season compared to the dry season55. Malaria in the study area is meso-endemic but geographically 
heterogeneous, with prevalence estimates ranging from 14.6% on islands to 44.2% in the coastal mainland21. The 
major vector responsible for malaria transmission in Lake Victoria is Anopheles gambiae s.l.56, and estimated 
annual EIR from serological markers were reported as high as 50 infectious bites per person per year14. P. falci-
parum is the predominant malaria parasite, while Plasmodium malariae and Plasmodium ovale are less common, 
and no Plasmodium vivax infections are observed21.
In this study, seven catchment areas on Mfangano (i.e. large island) were selected to represent the different 
local environments found on the island. Gulwe and Kagungu are situated in the central highland. On the other 
hand, Ramba, Wakinga, Mrongo, Ugina and Wakula are situated along the coastal lowlands of the island. Across 
the island, there are six government health facilities including one health centre and five dispensaries. Meanwhile, 
on each small island, population is mainly distributed between two main settlements: Kamarach and Kongata on 
Takawiri Island, Kibuogi A and Kibuogi B on Kibuogi Island, and Bonde and Luanda on Ngodhe Island. Takawiri 
and Kibuogi are close to Mfangano while Ngodhe is situated to the north of Rusinga Island. Takawiri and Ngodhe 
are each served by a dispensary, but no public health facility is available on Kibuogi. Ungoye, a small village on 
the mainland was included for comparative purposes due to its similarity to the islands in environmental charac-
teristics, infrastructure, and access to the health facilities. It is served by a government dispensary. The village is 
connected by an unpaved road to the nearby towns of Sindo and Mbita, each with a sub-district hospital.
Ethical consideration. This study was carried out in full accordance with all international, Kenyan 
and Swedish accepted guidelines as written informed consent was obtained from all participants. The Ethics 
Committee reviewed and approved all the consent procedures. This study was approved by the Kenyatta National 
Hospital/University of Nairobi-Ethics and Research Committee in Kenya (No.P7/1/2012) and the Committee on 
the Ethics of Human Research of Karolinska Institutet in Sweden (Dnr 201271239–31/4).
Sample collections. Two cross-sectional surveys were performed in January and August 2012, after the 
short and long rainy seasons, respectively. Both surveys were conducted approximately 2 months after the rainy 
seasons to coincide with the periods of heaviest malaria burden. In our effort to ensure a high coverage of sam-
pled population, each survey was conducted on different parts of the five study settings. The convenience sam-
pling strategy was used in this study, whereby residents were asked to come to selected survey points such as 
community-based beach management unit (BMU) halls or school for study participation. Island and village lead-
ers were sensitised to study by trained field workers and together provided information to community members 
at community meetings. Adult community members willing to participate were asked to read and provide sig-
nature on an informed consent form. In case of illiteracy, consent by thumb print was obtained in the presence 
of an independent literate adult witness. For children ≤12 years of age, consent was obtained from parents or 
guardians.
Different catchment areas were targeted in each survey (Fig. 1). On Mfangano Island, three (i.e. Gulwe, 
Ramba, Wakinga) and four (i.e. Kagungu, Mrongo, Ugina, Wakula) catchment areas were surveyed in January 
and August, respectively. Except for Wakula and Ugina where surveys were conducted in BMU halls, primary 
school surveys were carried out in other catchment areas on Mfangano. The intra-island epidemiology of malaria 
in this island has been described in detail elsewhere21. On each small island, surveys were conducted separately 
between the two main settlements: Kamarach, Kibuogi A and Bonde in January and Kongata, Kibuogi B and 
Luanda in August. All surveys on small islands were conducted at BMU halls, which are typically connected to 
marketplaces.
To ensure a balanced representation of all age groups, five age categories were defined per study area: one 
to five years, six to ten years, 11–15 years, 16–30 years, and >30 years. Age and gender of each participant were 
recorded. Axillary body temperature was determined using a digital thermometer (Terumo, New Jersey, US), 
and those with temperature exceeding 37.5 °C were considered febrile. Haemoglobin level was measured with 
the HemoCue Hb 201 Analyzer (HemoCue, Angelholm, Sweden). A measurement below 11 g/dL was classified 
as anaemic. Children aged 12 years and below were examined for enlarged spleen by AK according to Hackett’s 
method, regardless of fever or malaria status.
Parasite detection by microscopy and PCR. A blood sample was obtained by finger prick (approxi-
mately 10 µl) for thick and thin blood smears, and two spots of blood (70 µl each) were collected on Whatman 
ET31 Chr filter paper (Whatman, UK). Blood spots on filter paper were air-dried and stored in plastic bags at 
4 °C short term and at −20 °C for longer term. Blood smears were stained with Giemsa solution and examined for 
the presence of P. falciparum parasite in 100 high-power fields by experienced microscopists as described previ-
ously21. Parasite density was determined by counting the number of asexual parasites against 200 leukocytes and 
assuming that there are 8,000 leukocytes per µl of blood. DNA was extracted from a quartered blood spot (17.5 µl) 
using the QIAamp Blood Mini Kit (QIAGEN, Germantown, USA) according to the manufacturer’s instructions. 
The presence of P. falciparum DNA was assessed using a nested PCR protocol (nPCR) as described previously57.
Serological assays. A 3 mm disk was punched from each dried blood spot and serum was eluted in recon-
stitution buffer in 0.5 ml deep well plates (Corning Costar, PA, USA) as described previously58. The reconstituted 
blood spot solution, equivalent to a 1/200 dilution of serum, was stored at 4 °C until used for antibody test.
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All sera were tested for IgG antibodies by indirect quantitative enzyme-linked immunosorbent assay (ELISA) 
to two recombinant blood-stage P. falciparum malaria antigens namely apical membrane antigen-1 (AMA-1, 
3D7) and merozoite surface protein-1 (MSP-119, Wellcome genotype), as well as to the P. falciparum sporozoite 
antigen NANP5 repeat peptide circumsporozoite protein (CSP) (Alpha Diagnostic International, USA). Briefly, 
antigens were coated on NUNC-Immuno plates (Sigma) at concentrations of 0.5 µg/ml and 1.0 µg/ml in coating 
buffer (50 µl per well) for recombinant blood-stage antigens (AMA-1 and MSP-119) and CSP, respectively. The 
plates were washed in PBS with 0.05% Tween 20 (PBS/T) and blocked using 1% (w/v) skimmed milk solution 
(Sigma, USA) in PBS/T for three hours. After washing, 50 µl of reconstituted blood spot solution were added in 
duplicate at final dilutions of 1:1000 for both MSP-119 and CSP, and 1:2000 for AMA-1 and incubated overnight 
at 4 °C. A positive control consisting of a pool of hyper-immune sera was included in each plate. The plates 
were washed and 50 µl of horse-radish peroxidase (HRP)-conjugated rabbit anti-human IgG antibody (DAKO, 
Denmark) were added to all wells at a dilution 1:15,000 in PBS/T and incubated for three hours. After further 
series of washes, 100 µl of the substrate solution 3,3′,5,5′-tetramethylbenzidine (TMB) (tebu-bio laboratories, 
France) were added. Reactions were stopped after 15 minutes with 50 µl per well of 0.2 M H2SO4. The optical den-
sity (OD) at 450 nm was read using Multiskan Go ELISA reader (Thermo Fisher Scientific, USA).
Data analysis. Statistical analysis was performed using STATA/SE version 13.1 (StataCorp, TX, USA) 
and GraphPad Prism Software version 5.03 (GraphPad Software Inc., CA, USA). Duplicate ELISA OD values 
were averaged and normalised against values from blank wells as previously described to adjust for background 
reactivity58. Seropositivity was determined by fitting a mixture model to normalised OD values assuming two 
Gaussian distributions, one for sero-negative individuals and another for sero-positive individuals25. The mean 
OD plus three standard deviations associated with the sero-negative group was used as the cut-off value for 
seropositivity. A separate cut-off was generated for each antigen. Differences in parasite prevalence and seroprev-
alence estimates between study areas and age categories were performed using a two-sided test for proportions 
and the corresponding exact binomial 95% confidence intervals (95% CIs). The titre of antibody responses was 
estimated using the equation dilution/[maximum OD/(OD test serum – minimum OD) – 1]; the median titre 
and interquartile range (IQR) are given. Differences in antibody responses were assessed using age-adjusted lin-
ear regression. Seroprevalence was stratified into yearly age groups and then analysed using a reverse catalytic 
modelling approach under a binomial sampling assumption, as described elsewhere9, 10, 13. This method provides 
estimates of the mean annual rates of conversion to seropositive (seroconversion rate, SCR [λ]) and reversion 
to seronegative (seroreversion rate, SRR [ρ]) status, averaged over the age of the population. The common SRR 
was estimated from the model using maximum likelihood as described previously9. Infant under 1 year of age 
were excluded to remove any influence of maternally derived antibodies9. The serologically-derived annual EIR 
was estimated using AMA-1 and MSP-119 seroconversion rates and a calibration curve derived from determined 
values10. Factors associated with P. falciparum seropositivity were determined for each site separately using gener-
alised estimating equations adjusting for correlation between observations from the same variables. The following 
factors were included: age in years, gender, fever, anaemia and enlarged spleen (children ≤12 years old). Variables 
that were significant at P < 0.10 in the univariate analyses were added to the multivariate model and retained in 
the final multivariate model if their association with immune responses was statistically significant at P < 0.05.
Data availability. The datasets generated during and/or analysed during the current study are available from 
the corresponding author on reasonable request.
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